openPR Logo
Press release

Rising Prevalence Of Skin Cancer Drives Growth In The Photodynamic Therapy Market Driver: Leading Transformation in the Photodynamic Therapy Market in 2025

03-06-2025 09:55 AM CET | Health & Medicine

Press release from: The Business Research Company

Photodynamic Therapy

Photodynamic Therapy

What industry-specific factors are fueling the growth of the photodynamic therapy market?
The escalation in occurrences of skin cancer is facilitating the expansion of the photodynamic therapy market. Skin cancer is reported to be the most widespread type of cancer. Melanoma, despite accounting for roughly 1% of skin cancers, leads to a considerable number of deaths from skin cancer. Photodynamic therapy (PDT) leverages a blend of a light-sensitive medication and extreme light to annihilate cancer cells. The physician applies the light-sensitive chemical-infused lotion onto the skin cancer and its surroundings. For example, in January 2024, the American Cancer Society, a professional organization based in the U.S., reported that skin cancer is the most common cancer in the U.S., with melanoma making up about 1% of cases yet accounting for most skin cancer deaths. Moreover, it is anticipated that in 2024, about 100,640 new melanoma cases will be identified in the U.S., roughly 59,170 in men and 41,470 in women. An estimated 8,290 deaths from melanoma are expected, including approximately 5,430 among men and 2,860 among women. Hence, the growing occurrence of skin cancer is projected to stimulate the expansion of the photodynamic therapy market in future years.

Get Your Photodynamic Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

What Is the projected market size and growth rate for the photodynamic therapy market?
In recent times, the photodynamic therapy market has witnessed significant growth. The market is projected to expand from a size of $1.45 billion in 2024 to about $1.55 billion in 2025. This represents a robust compound annual growth rate (CAGR) of 7.0%. Various factors contributing to this growth during the historical period include a growing elderly population, increasing instances of cancer and skin diseases, rising levels of pollution, greater healthcare spending, and an expansion in the number of healthcare facilities.

It is projected that the photodynamic therapy market will experience notable expansion in the coming years, expected to reach $2 billion by 2029 with a compound annual growth rate of 6.5%. This anticipated expansion during the forecast period is attributable to factors such as increased spending on healthcare, insurance coverage for photodynamic therapy, promising potential growth in developing economies, a surge in the teenage population, rising elderly population, growing prevalence of cancer and chronic diseases, and the emergence of infectious diseases. Pertinent trends projected for the forecast period include the advent of a portable photodynamic therapy device enabling at-home dermatological PDT treatments, investment in AI-powered PDT for enhanced patient care, product portfolio expansion in cosmetic procedures, continued investment in research and development and a focus on providing photoimmunotherapy devices as well as broadening the portfolio to introduce photothermal therapy.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What trends are poised to drive the future success of the photodynamic therapy market?
The photodynamic therapy market is witnessing a growing trend of clinical trials focusing on the combination of PDT with various drugs. For example, in February 2024, Kintara Therapeutics, a biotechnology firm based in the United States, embarked on a clinical trial for its REM-001 therapy, which targets cutaneous metastatic breast cancer. The clinical trial, identified as NCT05374915, is an open-label study that involves 15 patients with cutaneous metastatic breast cancer. It evaluates the second-generation photodynamic therapy agent known as REM-001 at a dosage of 0.8 mg. The goal of the study is to refine the design of the trial before proceeding to a Phase 3 trial, with a major emphasis on achieving the Best Overall Objective Response Rate (bORR) within the first 24 weeks of treatment. The primary endpoint involves the assessment of complete and partial responses.

What major market segments define the scope and growth of the photodynamic therapy market?
The photodynamic therapy market covered in this report is segmented -

1) By Product: Drugs, Devices
2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications
3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:
1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations
2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

Which region dominates the photodynamic therapy market?
North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the photodynamic therapy industry growth?
Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Is Covered In The Photodynamic Therapy Global Market Report?

• Market Size Forecast: Examine the photodynamic therapy market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the photodynamic therapy market for a structured understanding.
• Key Players Overview: Analyze major players in the photodynamic therapy market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the photodynamic therapy market.
• Segment Contributions: Evaluate how different segments drive overall growth in the photodynamic therapy market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the photodynamic therapy market.
• Industry Challenges: Identify potential risks and obstacles affecting the photodynamic therapy market.
• Competitive Landscape: Review strategic developments in the photodynamic therapy market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence Of Skin Cancer Drives Growth In The Photodynamic Therapy Market Driver: Leading Transformation in the Photodynamic Therapy Market in 2025 here

News-ID: 3900870 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Photodynamic

Driving Photodynamic Therapy Market Growth in 2025: The Role of Rising Prevalenc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Photodynamic Therapy Market Size Growth Forecast: What to Expect by 2025? Growth within the photodynamic therapy market size has seen a robust increase in recent years. The market size is predicted to rise from $1.45 billion in 2024 to $1.53 billion in 2025, demonstrating a compound annual growth rate
Photodynamic Therapy Market Competitive Analysis Forecast till 2030
According to Ameco Research 'Photodynamic Therapy Market report, the analysts took this into account when estimating the Photodynamic Therapy Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Photodynamic Therapy Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Photodynamic Therapy Market trends, segmentation, key
Photodynamic Therapy Market Report 2030
Photodynamic therapy market, a groundbreaking treatment, is reshaping the landscape of cancer therapy and dermatology. By harnessing the power of light and photosensitizing agents, PDT presents a promising solution in combating various cancers and skin conditions. With the global market projected to surge from USD 5 billion in 2021 to USD 18.1 billion by 2030, PDT is poised to revolutionize the medical sector. Download Sample Report Copy Of This Report From
Photodynamic Therapy Market | Share, Growth Report 2022 - 2030
The Photodynamic Therapy Market Research Report provides an in-depth analysis of the market dynamics, key players, and competitive landscape of the Photodynamic Therapy industry. It aims to provide valuable insights into the market trends, growth opportunities, and challenges faced by the industry stakeholders. The report serves as a comprehensive guide for businesses and investors looking to make informed decisions in the Photodynamic Therapy business. The Photodynamic Therapy Market share is influenced
Photodynamic Therapy Market - The future of targeted therapy: Empowering patient …
Newark, New Castle, USA: The "Photodynamic Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Photodynamic Therapy Market: https://www.growthplusreports.com/report/photodynamic-therapy-market/7676 This latest report researches the industry structure, sales, revenue,
Photodynamic Therapy Market: Illuminating a Brighter Future in Cancer Treatment …
Actinic keratosis, psoriasis, acne, rosacea, esophageal cancer, and basal cell carcinoma are considered to be the topmost risk factors that are boosting the demand for photodynamic therapy among the general population. However, the growing availability of FDA-approved photosensitizer drugs and laser systems is contributing to the increased adoption of novel and innovative technologies to treat various conditions of dermatology, ophthalmology, and oncology. According to the Skin Cancer Foundation, one in five